Selected research
Market Structure
Global Extended-release Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Extended-release Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Extended-release Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Extended-release Medication include Shanghai Shyndec Pharmaceutical, Takeda, Sanofi, Zhuhai Rundu Pharmaceutical, Johnson & Johnson, Novartis, Pfizer, Bayer and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Extended-release Medication market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Extended-release Medication and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Extended-release Medication revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Extended-release Medication market size, projected growth trends, production technologies, key applications, and end-use industries.
Extended-release Medication Segment by Company
Shanghai Shyndec Pharmaceutical
Takeda
Sanofi
Zhuhai Rundu Pharmaceutical
Johnson & Johnson
Novartis
Pfizer
Bayer
AbbVie
AstraZeneca
Endo Pharmaceuticals
Collegium Pharmaceutical, Inc
China Res Double-Crane
Extended-release Medication Segment by Type
Original Medication
Generic Medication
Extended-release Medication Segment by Application
Hospital
Drugstore
Other
Extended-release Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extended-release Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Extended-release Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extended-release Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Extended-release Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Extended-release Medication industry.
Chapter 3: Detailed analysis of Extended-release Medication companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Extended-release Medicationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Medication
- Generic Medication
Applications
- Hospital
- Drugstore
- Other
Companies covered
- Shanghai Shyndec Pharmaceutical
- Takeda
- Sanofi
- Zhuhai Rundu Pharmaceutical
- Johnson & Johnson
- Novartis
- Pfizer
- Bayer
- AbbVie
- AstraZeneca
- Endo Pharmaceuticals
- Collegium Pharmaceutical, Inc
- China Res Double-Crane
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Extended-release Medication Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Original Medication
- 1.2.3 Generic Medication
- 1.3 Market Analysis by Application
- 1.3.1 Global Extended-release Medication Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drugstore
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Extended-release Medication Growth Trends by Region
- 1.5.1 Global Extended-release Medication Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Extended-release Medication Market Size by Region (2021-2026)
- 1.5.3 Extended-release Medication Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Extended-release Medication Market Dynamics
- 2.1 Extended-release Medication Industry Trends
- 2.2 Extended-release Medication Industry Drivers
- 2.3 Extended-release Medication Industry Opportunities and Challenges
- 2.4 Extended-release Medication Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Extended-release Medication Revenue by Company (2021-2026)
- 3.2 Global Extended-release Medication Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Extended-release Medication Key Company Head office and Area Served
- 3.4 Global Extended-release Medication Company, Product Type & Application
- 3.5 Global Extended-release Medication Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Extended-release Medication Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Extended-release Medication Players Market Share by Revenue in 2025
- 3.6.3 2025 Extended-release Medication Tier 1, Tier 2, and Tier 3
4 Extended-release Medication Market by Type
- 4.1 Global Extended-release Medication Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Extended-release Medication Market Size by Type (2021-2032)
- 4.3 Global Extended-release Medication Market Size Share by Type (2021-2032)
5 Extended-release Medication Market by Application
- 5.1 Global Extended-release Medication Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Extended-release Medication Market Size by Application (2021-2032)
- 5.3 Global Extended-release Medication Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Shanghai Shyndec Pharmaceutical
- 6.1.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.1.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.1.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Shanghai Shyndec Pharmaceutical Extended-release Medication Product Portfolio
- 6.1.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Takeda Extended-release Medication Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sanofi Extended-release Medication Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Zhuhai Rundu Pharmaceutical
- 6.4.1 Zhuhai Rundu Pharmaceutical Company Information
- 6.4.2 Zhuhai Rundu Pharmaceutical Business Overview
- 6.4.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Zhuhai Rundu Pharmaceutical Extended-release Medication Product Portfolio
- 6.4.5 Zhuhai Rundu Pharmaceutical Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Johnson & Johnson Extended-release Medication Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Novartis
- 6.6.1 Novartis Company Information
- 6.6.2 Novartis Business Overview
- 6.6.3 Novartis Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Novartis Extended-release Medication Product Portfolio
- 6.6.5 Novartis Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pfizer Extended-release Medication Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Bayer Extended-release Medication Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 AbbVie
- 6.9.1 AbbVie Company Information
- 6.9.2 AbbVie Business Overview
- 6.9.3 AbbVie Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 AbbVie Extended-release Medication Product Portfolio
- 6.9.5 AbbVie Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 AstraZeneca Extended-release Medication Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Endo Pharmaceuticals
- 6.11.1 Endo Pharmaceuticals Company Information
- 6.11.2 Endo Pharmaceuticals Business Overview
- 6.11.3 Endo Pharmaceuticals Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Endo Pharmaceuticals Extended-release Medication Product Portfolio
- 6.11.5 Endo Pharmaceuticals Recent Developments
- 6.12 Collegium Pharmaceutical, Inc
- 6.12.1 Collegium Pharmaceutical, Inc Company Information
- 6.12.2 Collegium Pharmaceutical, Inc Business Overview
- 6.12.3 Collegium Pharmaceutical, Inc Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Collegium Pharmaceutical, Inc Extended-release Medication Product Portfolio
- 6.12.5 Collegium Pharmaceutical, Inc Recent Developments
- 6.13 China Res Double-Crane
- 6.13.1 China Res Double-Crane Company Information
- 6.13.2 China Res Double-Crane Business Overview
- 6.13.3 China Res Double-Crane Extended-release Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 China Res Double-Crane Extended-release Medication Product Portfolio
- 6.13.5 China Res Double-Crane Recent Developments
7 North America
- 7.1 North America Extended-release Medication Market Size (2021-2032)
- 7.2 North America Extended-release Medication Market Size by Type
- 7.2.1 North America Extended-release Medication Market Size by Type (2021-2026)
- 7.2.2 North America Extended-release Medication Market Size by Type (2027-2032)
- 7.2.3 North America Extended-release Medication Market Share by Type (2021-2032)
- 7.3 North America Extended-release Medication Market Size by Application
- 7.3.1 North America Extended-release Medication Market Size by Application (2021-2026)
- 7.3.2 North America Extended-release Medication Market Size by Application (2027-2032)
- 7.3.3 North America Extended-release Medication Market Share by Application (2021-2032)
- 7.4 North America Extended-release Medication Market Size by Country
- 7.4.1 North America Extended-release Medication Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Extended-release Medication Market Size by Country (2021-2026)
- 7.4.3 North America Extended-release Medication Market Size by Country (2027-2032)
- 7.4.4 North America Extended-release Medication Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Extended-release Medication Market Size (2021-2032)
- 8.2 Europe Extended-release Medication Market Size by Type
- 8.2.1 Europe Extended-release Medication Market Size by Type (2021-2026)
- 8.2.2 Europe Extended-release Medication Market Size by Type (2027-2032)
- 8.2.3 Europe Extended-release Medication Market Share by Type (2021-2032)
- 8.3 Europe Extended-release Medication Market Size by Application
- 8.3.1 Europe Extended-release Medication Market Size by Application (2021-2026)
- 8.3.2 Europe Extended-release Medication Market Size by Application (2027-2032)
- 8.3.3 Europe Extended-release Medication Market Share by Application (2021-2032)
- 8.4 Europe Extended-release Medication Market Size by Country
- 8.4.1 Europe Extended-release Medication Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Extended-release Medication Market Size by Country (2021-2026)
- 8.4.3 Europe Extended-release Medication Market Size by Country (2027-2032)
- 8.4.4 Europe Extended-release Medication Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Extended-release Medication Market Size (2021-2032)
- 9.2 China Extended-release Medication Market Size by Type
- 9.2.1 China Extended-release Medication Market Size by Type (2021-2026)
- 9.2.2 China Extended-release Medication Market Size by Type (2027-2032)
- 9.2.3 China Extended-release Medication Market Share by Type (2021-2032)
- 9.3 China Extended-release Medication Market Size by Application
- 9.3.1 China Extended-release Medication Market Size by Application (2021-2026)
- 9.3.2 China Extended-release Medication Market Size by Application (2027-2032)
- 9.3.3 China Extended-release Medication Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Extended-release Medication Market Size (2021-2032)
- 10.2 Asia Extended-release Medication Market Size by Type
- 10.2.1 Asia Extended-release Medication Market Size by Type (2021-2026)
- 10.2.2 Asia Extended-release Medication Market Size by Type (2027-2032)
- 10.2.3 Asia Extended-release Medication Market Share by Type (2021-2032)
- 10.3 Asia Extended-release Medication Market Size by Application
- 10.3.1 Asia Extended-release Medication Market Size by Application (2021-2026)
- 10.3.2 Asia Extended-release Medication Market Size by Application (2027-2032)
- 10.3.3 Asia Extended-release Medication Market Share by Application (2021-2032)
- 10.4 Asia Extended-release Medication Market Size by Country
- 10.4.1 Asia Extended-release Medication Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Extended-release Medication Market Size by Country (2021-2026)
- 10.4.3 Asia Extended-release Medication Market Size by Country (2027-2032)
- 10.4.4 Asia Extended-release Medication Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Extended-release Medication Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Extended-release Medication Market Size by Type
- 11.2.1 South America, Middle East & Africa Extended-release Medication Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Extended-release Medication Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Extended-release Medication Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Extended-release Medication Market Size by Application
- 11.3.1 South America, Middle East & Africa Extended-release Medication Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Extended-release Medication Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Extended-release Medication Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Extended-release Medication Market Size by Country
- 11.4.1 South America, Middle East & Africa Extended-release Medication Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Extended-release Medication Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Extended-release Medication Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Extended-release Medication Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst